// App-Quantinova.ai

TCT-448 : Transcatheter aortic valve replacement for isolated severe native aortic valve regurgitation – results from the TAVR-NAVR Registry

Researchers

Presenter

  • Ole De Backer

Principal Investigators

  • Lars Sondergaard

  • Matheus Simonato dos Santos

  • G. Burkhard Mackensen

  • Alfredo Cerillo

  • Joachim Schofer

  • Nicolas Amabile

  • Guy Achkouty

  • Ulrich Schafer

  • Marcus-Andre Deutsch

  • Jan-Malte Sinning

  • David Hildick-Smith

  • Nicolas Van Mieghem

  • Stephan Windecker

  • Won Kim

  • Thierry Lefevre

  • Moritz Seiffert

  • Sabine Bleiziffer

  • Anna Sonia Petronio

  • Maurizio Taramasso

  • Azeem Latib

  • Danny Dvir

Medical Centers

  • University Heart Center Hamburg, Hamburg, Germany

  • Division of Cardiology, Institut Mutualiste Montsouris, Paris, France

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • University of Bonn, Bonn, Germany

  • Department of Anesthesiology & Pain Medicine, Seattle, Washington, United States

  • Medical Care Center Prof. Mathey, Prof. Schofer and Albertinen Heart Center, Hamburg, Hamburg, Germany

  • Kerckhoff Heart Center, Bad Nauheim, Germany

  • Rigshospitalet, Copenhagen, Denmark

  • Fondazione Toscana G. Monasterio, Massa, Massa and Carrara, Italy

  • Royal Sussex County Hospital, Brighton, United Kingdom

  • University Hospital of Bern, Bern, Switzerland

  • Centre for Heart Valve Innovation, St. Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada

  • Ramsay Générale de Santé, Institut Cardiovasculaire Paris-Sud, Massy, France

  • German Heart Center Munich, Munich, Germany

  • Interventional Cardiology Institute San Raffaele Hospital, Milan, Italy

  • Ospedale Cisanello Pisa, Pisa, Italy

  • Imm, Paris, France

  • Federal University of Sao Paulo, Sao Paulo, São Paulo, Brazil

  • Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark

Locations

  • Germany

  • France

  • Brazil

  • Switzerland

  • Italy

  • Denmark

  • Canada

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Aortic regurgitation

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved